(PharmaNewsWire.Com, September 29, 2017 ) Alcoholic hepatitis is an inflammation of the liver. It is typically caused by excessive alcohol consumption over a long period of time. Symptoms include changes in appetite, dry mouth, weight loss, yellowing of the skin or eyes (jaundice), fever and fatigue. Risk factors include alcohol use, obesity and genetic factors. Treatment includes corticosteroids and liver transplant.
Report Highlights
Publisher's Pharmaceutical and Healthcare latest pipeline guide Alcoholic Hepatitis-Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Alcoholic Hepatitis (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Alcoholic Hepatitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Alcoholic Hepatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 1, 6, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.
Alcoholic Hepatitis (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
List of Tables Number of Products under Development for Alcoholic Hepatitis, H2 2017 Number of Products under Development by Companies, H2 2017 Number of Products under Development by Universities/Institutes, H2 2017 Products under Development by Companies, H2 2017 Products under Development by Universities/Institutes, H2 2017 Number of Products by Stage and Target, H2 2017 Number of Products by Stage and Mechanism of Action, H2 2017 Number of Products by Stage and Route of Administration, H2 2017 Number of Products by Stage and Molecule Type, H2 2017 Alcoholic Hepatitis-Pipeline by Alfact Innovation, H2 2017 Alcoholic Hepatitis-Pipeline by Generon (Shanghai) Corp Ltd, H2 2017 Alcoholic Hepatitis-Pipeline by Gilead Sciences Inc, H2 2017 Alcoholic Hepatitis-Pipeline by GRI Bio Inc, H2 2017 Alcoholic Hepatitis-Pipeline by Immuron Ltd, H2 2017 Alcoholic Hepatitis-Pipeline by Intercept Pharmaceuticals Inc, H2 2017 Alcoholic Hepatitis-Pipeline by Promethera Biosciences SA, H2 2017 Alcoholic Hepatitis-Pipeline by Verlyx Pharma Inc, H2 2017 Alcoholic Hepatitis-Pipeline by Vital Therapies Inc, H2 2017 Alcoholic Hepatitis-Dormant Projects, H2 2017
List of Figures Number of Products under Development for Alcoholic Hepatitis, H2 2017 Number of Products under Development by Companies, H2 2017 Number of Products by Targets, H2 2017 Number of Products by Stage and Targets, H2 2017 Number of Products by Mechanism of Actions, H2 2017 Number of Products by Stage and Mechanism of Actions, H2 2017 Number of Products by Routes of Administration, H2 2017 Number of Products by Stage and Routes of Administration, H2 2017 Number of Products by Molecule Types, H2 2017 Number of Products by Stage and Molecule Types, H2 2017
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: